Form4insider filings, from the source

SEC Form 4 · accession 0000899243-16-036013

Calithera Biosciences, Inc. · CALA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Susan Molineaux
Officer — PRESIDENT AND CEO · Director
Period of report
Dec 19, 2016
Accepted (ET)
Dec 20, 2016 · 9:00 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001496671

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Dec 19, 2016M6,306$0.96A8,183D
Common StockF1Dec 19, 2016M15,627$2.64A23,810D
Common StockF2holding———313,336IBy Trust
Common Stockholding———12,044IBy Spouse

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (Right to Buy)F3$0.96Dec 19, 2016M6,306D—May 22, 2023Common Stock6,3067,568D
Employee Stock Option (Right to Buy)F4$2.64Dec 19, 2016M15,627D—Dec 16, 2023Common Stock15,62742,021D
Employee Stock Option (Right to Buy)F3$0.96Dec 19, 2016M5,418D—May 22, 2023Common Stock5,4186,502I
Employee Stock Option (Right to Buy)F4$2.64Dec 19, 2016M4,749D—Dec 16, 2023Common Stock4,7499,498I

Explanation of responses